| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.59B | 70.17B | 55.64B | 38.29B | 44.32B | 40.00B |
| Gross Profit | 30.99B | 33.80B | 27.14B | 17.10B | 20.23B | 17.02B |
| EBITDA | 18.29B | 22.04B | 15.42B | 7.52B | 11.36B | 10.19B |
| Net Income | 9.90B | 12.06B | 8.81B | 4.13B | 7.53B | 8.24B |
Balance Sheet | ||||||
| Total Assets | 81.63B | 99.03B | 81.33B | 56.55B | 54.38B | 49.74B |
| Cash, Cash Equivalents and Short-Term Investments | 16.46B | 19.30B | 23.95B | 17.99B | 21.55B | 19.20B |
| Total Debt | 6.61B | 6.53B | 1.20B | 1.34B | 1.27B | 1.33B |
| Total Liabilities | 29.63B | 32.97B | 31.68B | 15.35B | 15.75B | 16.68B |
| Stockholders Equity | 52.00B | 66.05B | 49.65B | 41.20B | 38.63B | 33.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.47B | 8.06B | -1.53B | 4.55B | 4.23B |
| Operating Cash Flow | 0.00 | 12.90B | 15.10B | 4.84B | 8.39B | 7.38B |
| Investing Cash Flow | 0.00 | -21.69B | -7.83B | -7.50B | -2.27B | -1.94B |
| Financing Cash Flow | 0.00 | 3.28B | -1.44B | -2.17B | -2.48B | -1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥3.75T | 25.03 | 53.12% | 1.11% | 32.51% | 57.19% | |
78 Outperform | ¥2.00T | 15.60 | 21.73% | 2.29% | 11.29% | 11.38% | |
77 Outperform | ¥17.43T | 45.29 | 47.37% | 0.25% | 63.36% | 149.43% | |
77 Outperform | ¥652.44B | 24.84 | 12.66% | 2.28% | 9.53% | -11.17% | |
75 Outperform | ¥7.26T | 35.55 | 25.78% | 0.79% | 13.45% | 20.37% | |
71 Outperform | ¥492.04B | 22.63 | ― | 1.02% | 29.60% | 24.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |